Mechanism of bromocriptine-induced hyperglycaemia.
Results reveal that bromocriptine at a dose of 6 mg/kg. I.P. in mice caused a significant hyperglycaemic effect which was accompanied by a marked increase in liver glycogen. After adrenalectomy, the effect of bromocriptine on serum glucose level was reduced whereas its effect on liver glycogen content was abolished. In rats, administration of bromocriptine (17.5 mg/kg I.P.) induced a significant rise in serum glucose level which was associated with marked reduction in serum insulin activity and increase in serum corticosterone level with no effect on serum triiodothyronine (T3) or thyroxine (T4) levels. It could be concluded that bromocriptine-induced hyperglycaemia might be attributed at least partially to inhibition of insulin release and stimulation of corticosterone secretion.
D000315:Adrenalectomy; D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology*; D003345:Corticosterone / Q000097:blood; D006943:Hyperglycemia / Q000139:chemically induced*; D007328:Insulin / Q000097:blood; D008112:Liver Glycogen / Q000032:analysis; D008297:Male; D051379:Mice; D051381:Rats; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D007328:Insulin; D008112:Liver Glycogen; D014284:Triiodothyronine; D001971:Bromocriptine; D013974:Thyroxine; D003345:Corticosterone